Literature DB >> 21143520

Adaptive immune responses during acute uncomplicated and fulminant hepatitis E.

Ratika Srivastava1, Rakesh Aggarwal, Sanjeev Sachdeva, Mohammad Intakhab Alam, Shahid Jameel, Sita Naik.   

Abstract

BACKGROUND AND AIM: Hepatitis E virus (HEV) infection is endemic in several developing countries. Clinical manifestations of this infection vary widely from asymptomatic infection to uncomplicated acute viral hepatitis and fulminant hepatic failure. The pathogenesis of this disease and the reason of varying disease severity remain unknown. In viral infections, tissue injury can be caused either by virus itself or by host immune responses directed against infected cells. We therefore studied adaptive immune responses to HEV antigens in patients with hepatitis E of varying disease severity and healthy controls.
METHODS: Cytokine secreting CD4+ T cells and antibody-producing B cells specific for HEV were enumerated through intracellular cytokine staining and enzyme-linked immunosorbent spot assay, respectively.
RESULTS: Patients with fulminant hepatitis E had a less marked expansion of HEV-specific interferon-γ or tumor necrosis factor-a secreting CD4+ T cells than patients with uncomplicated hepatitis E and healthy controls. These patients also had fewer CD4+ T cells that produce γ-interferon or tumor necrosis factor-a upon in vitro polyclonal stimulation. In addition, patients with fulminant disease had a more marked expansion of B cells that can secrete immunoglobulin G anti-HEV than patients with uncomplicated infection and control patients.
CONCLUSION: These findings suggest that less-marked antiviral cellular immune responses and heightened antiviral humoral responses are associated with a more severe disease during HEV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21143520     DOI: 10.1111/j.1440-1746.2010.06356.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  16 in total

1.  Superinfective Hepatitis E Virus Infection Aggravates Hepatocytes Injury in Chronic Hepatitis B.

Authors:  Semvua Bukheti Kilonzo; Yong-Li Wang; Qun-Qun Jiang; Wen-Yu Wu; Peng Wang; Qin Ning; Mei-Fang Han
Journal:  Curr Med Sci       Date:  2019-10-14

2.  CD8+ lymphocytes but not B lymphocytes are required for protection against chronic hepatitis E virus infection in chickens.

Authors:  Eda Rogers; Stephanie Michelle Todd; Frank William Pierson; Scott P Kenney; Connie Lynn Heffron; Danielle M Yugo; Shannon R Matzinger; Elena Mircoff; Irene Ngo; Charles Kirby; Michaela Jones; Paul Siegel; Peter Jobst; Karen Hall; Robert J Etches; Xiang-Jin Meng; Tanya LeRoith
Journal:  J Med Virol       Date:  2019-07-25       Impact factor: 2.327

3.  Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation.

Authors:  M Carré; A Thiebaut-Bertrand; S Larrat; V Leroy; P Pouzol; N Sturm; S Lhomme; J-Y Cahn; F Garban; P Morand
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

Review 4.  Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis E Virus Genotype 1 and 2 Infections.

Authors:  Rakesh Aggarwal; Amit Goel
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

5.  Changes in gene expression in liver tissue from patients with fulminant hepatitis E.

Authors:  Anshu Naik; Amit Goel; Vinita Agrawal; Aditya N Sarangi; Nanda Chhavi; Vineeta Singh; Shahid Jameel; Rakesh Aggarwal
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

6.  NLRP3 Inflammasome Activation is a Prognostic Marker of Recovery in HEV-Infected Patients.

Authors:  Vikram Thakur; Radha Kanta Ratho; Mini P Singh; Yogesh Chawla; Sunil Taneja
Journal:  Curr Microbiol       Date:  2022-01-04       Impact factor: 2.188

7.  Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection.

Authors:  Anuradha S Tripathy; Rumki Das; Sanjay B Rathod; Vidya A Arankalle
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

8.  Cytokine Profiles and Cell Proliferation Responses to Truncated ORF2 Protein in Iranian Patients Recovered from Hepatitis E Infection.

Authors:  Reza Taherkhani; Fatemeh Farshadpour; Manoochehr Makvandi; Hamid Rajabi Memari; Ali Reza Samarbafzadeh; Nasrin Sharifi; Behrouz Naeimi; Saeed Tajbakhsh; Samad Akbarzadeh
Journal:  J Trop Med       Date:  2015-09-15

9.  Effect of pregnancy on anti-HEV antibody titres, plasma cytokines and the corresponding gene expression levels in the PBMCs of patients presenting with self-recovering clinical and subclinical hepatitis E.

Authors:  Ashwini Y Ramdasi; Ravi P Arya; Vidya A Arankalle
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

Review 10.  Hepatitis E Pathogenesis.

Authors:  Sébastien Lhomme; Olivier Marion; Florence Abravanel; Sabine Chapuy-Regaud; Nassim Kamar; Jacques Izopet
Journal:  Viruses       Date:  2016-08-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.